Drugs / Gymnema Sylvestre
Gymnema Sylvestre
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02708966 | Mar 2016 → Sep 2018 | glucose intolerance | University of Guadalajara | Completed | No outcome recorded |
| Phase 2 | NCT02370121 | Feb 2013 → Dec 2014 | metabolic syndrome X | University of Guadalajara | Completed | Missed primary |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Gymnema Sylvestre | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02370121 ↗ |
| Action | Inhibit | “Gymnemic acids inhibit sodium-dependent glucose transporter 1.” PMID 24856809 ↗ Jun 2014 |
| Modality | Traditional medicine (herbal / TCM) | “Gymnema sylvestre (Asclepiadaceae), popularly known as "gurmar" for its distinct property as sugar destroyer, is a reputed herb in the Ayurvedic system of medicine.” PMID 24511547 ↗ Jan 2014 |
| Route | Oral | “The patients received 300 mg capsules of Gymnema sylvestre or placebo, two times daily before breakfast and dinner for 90 days.” NCT02370121 ↗ |